Study on tolerance to ischemia-reperfusion injury and protection of ischemic preconditioning of type1 diabetes rat heart

Biomedicine and Aging Pathology

Volumn 1, Issue 1, 2011, Pages 56-60

  Wang, Shi Ting ^a   Xu, Mang Hua ^a   Chen, Wen Ting ^a   Gao, Feng Hou ^a   Guo, Zhu Ying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Ischemia reperfusion; Ischemic preconditioning; Tolerance; Type1 diabetes

Indexed keywords

CREATINE KINASE; GLUCOSE; LACTATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DISEASE EXACERBATION; ELECTRON MICROSCOPE; ENZYME ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY; REVIEW; ULTRASTRUCTURE;

EID: 79960439196     PISSN: 22105220     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomag.2010.09.004     Document Type: Review

References (12)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74(5):1124-36. (Pubitemid 17174962)
2. Tani M, Neely JR. Hearts from diabetic rats are more resistant to in vitro ischemia: possible role of altered Ca2+ metabolism. Circ Res 1988;62(5):931-40.
3. Chen H, Shen WL, Wang XH, et al. Paradoxically enhanced heart tolerance to ischaemia in type1 diabetes and role of increased osmolarity. Clin Exp Pharmacol Physiol 2006;33(10):910-6. (Pubitemid 44427313)
4. Tao L, Meiying X, Dawei D, et al. Increased tolerance to ischemia/reperfusion injury in isolated diabetic rat hearts. Chin J Anesthesiol 2005;25(2):126-8.
5. Luan R, Liu S, Yin T, et al. High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res 2009;83(2):294-302.
6. Tsang A, Hausenloy DJ, Mocanu MM, et al. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005;54(8):2360-4. (Pubitemid 41134263)
7. Tosaki A, Engelman DT, Engelman RM, et al. The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 1996;31(4):526-36. (Pubitemid 26140063)
8. Ma G, Al-Shabrawey M, Johnson JA, et al. Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling. Naunyn Schmiedebergs Arch Pharmacol 2006;373(6):415-27. (Pubitemid 44401412)
9. Orchard TJ, Costacou T, Kretowski A, Nesto RW. Type1 diabetes and coronary artery disease. Diabetes Care 2006;29(11):2528-38. (Pubitemid 44912266)
10. Galinanes M, Fowler AG. Role of clinical pathologies in myocardial injury following ischaemia and reperfusion. Cardiovasc Res 2004;61(3):512-21. (Pubitemid 38210156)
11. Shi-Ting Wang, Zhu-Ying Guo, Mang-Hua Xu, Feng-Hou Gao. Role of calcitonin gene-related peptide and IP3 pathway in ischemic preconditioning in isolated perfused hearts of rats with type1 diabetes mellitus. Shanghai Jiaotong Daxue Xuebao 2010;30(2):191-5.
12. Ferdinandy P, Schulz R, Baxter GF. Interactionof cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007;59(4):418-58.